Suchergebnisse
Suchergebnisse:
Vor 15 Stunden · Lilly is expected to post earnings of $2.65 per share for the current quarter, representing a year-over-year change of +25.6%. Over the last 30 days, the Zacks Consensus Estimate has changed -0.5% ...
Vor 15 Stunden · Why MariTide could have multiple advantages over other GLP-1 drugs. MariTide, also known as AMG 133, is a GLP-1 injectable treatment that pharmaceutical company Amgen (AMGN-0.65%) has been ...
Vor 15 Stunden · CHICAGO, May 17, 2024 /PRNewswire/ -- Active Pharmaceutical Ingredient Market in terms of revenue was estimated to be worth $163.5 billion in 2024 and is poised to reach $238.3 billion by 2029
Vor 15 Stunden · CHICAGO, May 17, 2024 /PRNewswire/ -- Active Pharmaceutical Ingredient Market in terms of revenue was estimated to be worth $163.5 billion in 2024 and is poised to reach $238.3 billion by 2029, growing at a CAGR of 7.8% from 2024 to 2029 according to a new report by MarketsandMarkets™. The growth of this market is driven by increasing demand ...
Vor 11 Stunden · Skeptics say keeping muscle less important than losing weight. Companies are testing drugs first developed for other diseases. The new blockbuster weight-loss shots can help patients trim more pounds than any medicines have before. Now drugmakers are rushing to solve another problem — making sure people keep their muscle even as they shed fat.
Vor 2 Stunden · Eli Lilly NYSE:LLY is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock.Over the past month, shares of this drugmaker have returned +3.4%, compared to the Zacks S&P 500 comp…
Vor 15 Stunden · The word on The Street in general, suggests a Strong Buy analyst consensus rating for Eli Lilly & Co with a $881.00 average price target, representing a 12.3% upside. In a report issued on May 8 ...
